MMA Embolization for Refractory Chronic Migraine
50
about 3.7 years
18–65
9 sites in AZ, CA, CT +4
Why this study is shown
What this study is about
Researchers are testing a new way to treat severe migraines that haven't responded to other treatments. The treatment involves blocking blood flow in the middle meningeal artery using a device. The trial will last about 1346 days and aims to enroll around 50 adults.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use Middle Meningeal Artery embolization
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Change from baseline, in number of migraine days
Secondary: Change from baseline in migraine days frequency
Neurology